What started out with the US imposing tariffs on a number of trade partners, causing markets to drop early Monday, ended with 30-day tariff pauses on Canada and Mexico ... (CARR), Edwards Lifesciences ...

Epclusa (sofosbuvir, velpatasvir) Gilead Sciences Canada - Epclusa is used in the treatment of adults ... stroke and urgent coronary revascularisation) in patients with a history of myocardial ...

Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance ...

Gilead Sciences Inc. closed 0.11% below its 52-week high of $112.11, which the company reached on February 25th.

Investors with a lot of money to spend have taken a bullish stance on Gilead Sciences GILD ... showed up on publicly available options history that we track here at Benzinga.

Gilead Sciences’s recent history shows its demand slowed as its annualized revenue growth of 2.7% over the last two years is below its five-year trend.

Gilead Sciences has a 52-week low of $62.07 and a 52-week high of $111.03. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.20 and a current ratio of 1.50.

Gilead Sciences has a fifty-two week low of $62.07 and a fifty-two week high of $106.69. Gilead Sciences ( NASDAQ:GILD – Get Free Report ) last posted its earnings results on Tuesday, February 11th.

16 analysts have shared their evaluations of Gilead Sciences GILD during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other Renaissance Technologies portfolio’s top stock picks. The American quant hedge ...

Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives ...